Mutations or deficiencies in the FANCJ gene are associated with an increased risk of developing certain types of cancer, particularly breast cancer and ovarian cancer. The protein encoded by FANCJ interacts with BRCA1, another well-known cancer susceptibility gene. Disruptions in these interactions can impair the DNA repair pathways, leading to the accumulation of mutations and cancer development.
